Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||||
|
0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||||
|
0.716 | 0.200 | 12 | 68808384 | 5 prime UTR variant | A/G | snv | 0.37 |
|
Neoplasms; Eye Diseases | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||||
|
0.882 | 0.040 | 12 | 68839592 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2004 | |||||||
|
0.882 | 0.040 | 12 | 68839592 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2004 | |||||||
|
0.882 | 0.040 | 12 | 68839592 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2004 | |||||||
|
0.925 | 0.080 | 12 | 68839568 | missense variant | A/G | snv | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 12 | 68839568 | missense variant | A/G | snv | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 12 | 68828783 | missense variant | A/G | snv | 2.8E-05 | 2.0E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.925 | 0.080 | 12 | 68828783 | missense variant | A/G | snv | 2.8E-05 | 2.0E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.925 | 0.080 | 12 | 68839466 | missense variant | A/G | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 12 | 68839466 | missense variant | A/G | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||
|
0.807 | 0.080 | 12 | 68839587 | missense variant | A/G | snv | 1.5E-04 | 5.1E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
12 | 68847050 | 3 prime UTR variant | A/G | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.763 | 0.240 | 12 | 68809243 | missense variant | A/G | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.763 | 0.240 | 12 | 68809243 | missense variant | A/G | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 |